February 1, 2023

Two early stage clinical studies testing the safety and efficacy of 40Hz sensory stimulation to treat Alzheimer’s disease have found that the potential therapy was well tolerated, produced no serious adverse effects and was associated with some significant neurological and behavioral benefits among a small cohort of participants.


Leave a Reply

Your email address will not be published. Required fields are marked *